JoyceMTengMDPhD

Dermatology • Palo Alto, CA

Pediatric Dermatology

Associate Professor, Dermatology, Stanford University

Join to view full profile

Dr. Teng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Teng's full profile

Already have an account?

Office
725 Welch Rd
Palo Alto, CA 94304
Phone+1 650-497-8000

Fax+1 650-721-5526

Education & Training

University of ColoradoFellowship, Pediatric Dermatology, 2005 - 2006
Vanderbilt University Medical CenterResidency, Dermatology, 2002 - 2005
Vanderbilt University Medical CenterInternship, Transitional Year, 2001 - 2002
Vanderbilt University School of MedicineClass of 2001
Memorial Sloan Kettering Cancer CenterPost-Doctoral Fellowship, 1994 - 1997

Certifications & Licensure

CA State Medical License 2012 - 2026
WI State Medical License 2006 - 2013
CO State Medical License 2005 - 2007
American Board of Dermatology Dermatology
American Board of Dermatology Pediatric Dermatology

Awards, Honors, & Recognition

Member Women's Dermatologic Society
Member Society of Pediatric Dermatology
Member Dermatology Foundation
Member American Academy of Pediatrics
Fellow (FAAD) American Academy of Dermatology
Fellow (FASDS) American Society for Dermatologic Surgery
Join now to see all

Clinical Trials

Musculoskeletal Effects of Isotretinoin During Acne Treatment in Pediatric Population Start of enrollment: 2008 Jul 01
Terminated
Topical Sirolimus for Plantar Keratoderma in Adults With Pachyonychia Congenita (PC) Start of enrollment: 2014 Jan 01
Computational Drug Repurposing for All EBS Cases Start of enrollment: 2017 Nov 28
Recruiting
Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita Start of enrollment: 2019 Apr 01
Active, not recruiting
Phase 2, Phase 3
Trametinib in the Treatment of Complicated Extracranial Arterial Venous Malformation Start of enrollment: 2020 Dec 01
Recruiting
Phase 2
CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome Start of enrollment: 2021 May 06
Recruiting
Phase 2
Topical Simvastatin for Treating Infantile Hemangioma Start of enrollment: 2024 Apr 01
Not yet recruiting
Early Phase 1
Roles: Contact, Sponsor-Investigator, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

78 citations
Genotype-Guided Medical Treatment of an Arteriovenous Malformation in a Child
Ramrada Lekwuttikarn, Young H. Lim, Shehla Admani, Keith A. Choate, Joyce M.C. Teng
JAMA Dermatology. 2019-02-01
77 citations
Self-initiated use of topical cannabidiol oil for epidermolysis bullosa.
Malcolm P. Chelliah, Zachary Zinn, Phoung Khuu, Joyce M.C. Teng
Pediatric Dermatology. 2018-07-01
36 citations
RASA1-dependent cellular export of collagen IV controls blood and lymphatic vascular development.
Di Chen, Joyce M.C. Teng, Paula E. North, Philip E. Lapinski, Philip D. King
The Journal of Clinical Investigation. 2019-09-03

Press Mentions

FDA Expands Approval of Two Plaque Psoriasis Therapies to Include Younger PatientsAugust 1st, 2019
LEO Pharma Inc. Announces U.S. Food and Drug Administration (FDA) ExpandedJuly 31st, 2019
Sirolimus Add-on Seen Helpful for Visible Arteriovenous MalformationsSeptember 20th, 2018
Join now to see all

Professional Memberships

American Academy of Dermatology - AAD
Fellow
American Society for Dermatologic Surgery - ASDS
Fellow

Other Languages

Chinese (Mandarin)